Transcranial Magnetic Stimulation
Deep TMS improves quality of life in treatment-resistant depression
SAN FRANCISCO — For patients with treatment-resistant major depressive disorder, deep transcranial magnetic stimulation significantly improved symptoms and quality of life compared with sham, according to a poster presented here.
VIDEO: Transcranial current stimulation improves fatigue in MS
BOSTON — Transcranial direct current stimulation of the dorsolateral prefrontal cortex increased activation of the area and improved self-reported fatigue in patients with MS, Giuseppina Pilloni, PhD, says in this Healio video.
Repetitive transcranial magnetic stimulation effective in major depression
Repetitive transcranial magnetic stimulation was effective in routine treatment of medication-resistant major depression, according to findings published in the Journal of Affective Disorders.
New developments in interventional psychiatry: What primary care providers should know
In early September, the FDA granted Breakthrough Device Designation and cleared the SAINT Neuromodulation System for treatment-resistant depression, or TRD.
D-cycloserine enhances TMS treatment for depression
NMDA-receptor partial agonist D-cycloserine enhanced transcranial magnetic stimulation treatment outcomes in those with major depressive disorder, researchers reported.
FDA clears TMS treatment for MDD
BrainsWay Ltd. announced it has received 510(k) clearance from the FDA for its Deep TMS H7 Coil for use in treating adults with major depressive disorder, as well as comorbid anxiety.
FDA approves transcranial magnetic stimulation system for patients with anxious depression
The FDA has approved Neuronetics’ NeuroStar Advanced Therapy for Mental Health, a transcranial magnetic stimulation system for treatment of anxiety symptoms in adults with major depressive disorder, the company announced in a press release.